Francesco Montagnani

Ponderano, 13875, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening.

Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening.

Journal: Journal of translational medicine

Published: May 21, 2025

Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer.

Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer.

Journal: The oncologist

Published: January 03, 2025

Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice.

Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice.

Journal: Cancers

Published: December 23, 2022

Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.

Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.

Journal: Journal of chemotherapy (Florence, Italy)

Published: February 14, 2022

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.

Journal: JAMA network open

Published: July 22, 2021

A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.

A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 20, 2021

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 16, 2021

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum].

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum].

Journal: Cancer management and research

Published: May 09, 2019

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.

Journal: Clinical colorectal cancer

Published: January 22, 2019

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).

Journal: Cancer management and research

Published: December 06, 2018

Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials.

Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials.

Journal: OncoTargets and therapy

Published: October 29, 2018

Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.

Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.

Journal: British journal of cancer

Published: July 09, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026